Programme

Download Final Programme [PDF, 1,1 MB]

Certified with 15 CME-Points
Certified by the "Akademie für Fort-und Weiterbildung in der Radiologie".

Thursday, Oct. 22, 2009  
18:00
 General assembly
Working group nuclear medicine and radiooncology
of the DEGRO and the DGN                                 
   
   
Friday, Oct. 23, 2009  
08:30 Welcome
A.-L. Grosu, U. Nestle, O. Opitz, C. Peters
I
 		Visualisation of tumor biology: Hypoxia
Chairs: M. Baumann, A.-L. Grosu
09:00 Tumor hypoxia in the clinical setting: Current knowledge and unsolved problems
P. Vaupel, Munich
09:20 The Munich experience: From Eppendorf to imaging
M. Molls, Munich
09:40

The Nijmegen experience: Clinical and preclinical studies on tumor hypoxia

J. Bussink, Nijmegen
10:00 The Freiburg experience I: Are late enhancements and hypoxia equivalent
M. Hentschel, Freiburg
10:20 Coffee break

Chairs: M. Molls, P. Vaupel
10:40 The Oxford experience: Imaging the effects of signal transduction inhibitors in the context of radiotherapy
T. Brunner, Oxford 
11:00      

The Dresden experience: Verification of impact for radiotherapy
M. Baumann, Dresden

11:20 The Tübingen experience: Dose painting by numbers
D. Thorwarth, Tübingen
11:40 The Freiburg experience II:
Lessons from EPO
M. Henke, Freiburg

12.00

Lunch

II
 		Visualisation of tumor biology:
Proliferation, Vasculature, Receptors
Chairs: H. Mäcke, G. Niedermann
13:15
 Proliferation PET
J. Buck, Munich
13:35
 Imaging angiogenesis- the role of PET within a multimodality approach
A. Beer, Munich
13:55
 Functional imaging of tumor vasculature after antiangiogenic therapy
D. Duda, Bosten
14:15
 Nuclear medicine receptor imaging
M. Behe, Freiburg
14:35 Coffee break
  Chairs: J. Debus, M. Langer
14:55 New CT/MRI contrast media
I. Hilger, Jena
15:15
 Developments in ultrasound
F. Kiessling, Aachen
15:35
 MRI for visualisation of tumor biology
M. Büchert, Freiburg
15.55 Coffee break
III Image guided radiotherapy
Chairs: G. Bruggmoser, P. Lukas
16:15
 Cone beam CT, tracking, gating
U. Oelfke, Heidelberg
16.35
 IGRT
F. Röhner, Freiburg
16:55
 MRI in the radiotherapy treatment room
B. Raaymakers, Utrecht
17.15
 Tomotherapy
P. Kneschaurek, Munich
17.35
 Cyberknife
M. Hoogmann, Rotterdam
19:30
 		Social Dinner

 

 

Saturday, Oct. 24, 2009

 
IV
 PET in target volume definition

Physics
Chairs: P. Knetschaurek, M. Mix
08:40
 Image fusion
U. Pietrzyk, Jülich
09:00
 Physics of PET based TV- delineation
M. Mix, Freiburg
 

Lung cancer
Chairs: P. Lukas, U. Nestle

09:20 Chances and risks of the integration of PET-CT in radiotherapy treatment planning in lung cancer
D. De Ruysscher; Maastricht
09:40
 PET-based target volume definition in lung cancer
M. MacManus, Melbourne
10:00
The PET-plan trial: A prospective clinical study on patients' benefit by FDG-PET-based target volume definition
U. Nestle, Freiburg
10:20
 Coffee break

Brain
Chairs: F. Dhermain, H. Feldmann

10:40 Aminoacid-PET-based radiotherapy
A.-L. Grosu, Freiburg
11:00       Role of perfusion and permeability in gliomas
F. Dhermain, Villejuif
  Other sites
Chairs: F. Momm, M. Picchio
11:20 Impact of PET on RT-planning in breast cancer
I. C. Chiricuta, Limburg

11:40

Impact of PET on RT-planning in Hodgkins Lymphoma
C. Kobe, Cologne

12:00
 Choline-PET in restaging of prostate cancer
M. Picchio, Milano
12:20
 Choline-PET in localised prostate cancer and radiotherapy
B.-J. Krause, Munich
12:40

Neoadjuvant treatment of sarcomas and imaging
Y.-L. Chen, Boston

13:00
 Lunch
V
 Imaging for treatment monitoring and detection of recurrence
Chairs: M. MacManus, W. Weber
14:15
 CT/MRI:State of the art
M. Langer, Freiburg
14:35
 (FDG)-PET after chemo- and/or radiotherapy
W.Weber, Freiburg
14:55
 Side effects after radiotherapy in imaging
M. Puderbach, Heidelberg
15:15
 Closing remarks, Farewell
U. Nestle, A.-L.. Grosu
15:30
 End of meeting